help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bloesch, D.
Right arrow Articles by Stauffacher, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bloesch, D.
Right arrow Articles by Stauffacher, W.

Journal of Clinical Endocrinology & Metabolism, Vol 77, 1156-1163, Copyright © 1993 by Endocrine Society


ARTICLES

Effects of endotoxin on leucine and glucose kinetics in man: contribution of prostaglandin E2 assessed by a cyclooxygenase inhibitor

D Bloesch, U Keller, GA Spinas, D Kury, J Girard and W Stauffacher
Department of Research, University of Basel, Switzerland.

The effects of endotoxin (E) administration on whole body protein and glucose metabolism were studied in normal volunteers. Injection of 4 ng/kg Escherichia coli E iv resulted in a relative increase in leucine flux (1-13C-leucine infusion technique) compared to controls [+0.12 +/- 0.10 vs. -0.45 +/- 0.23 mumol/kg.min after 360 min, P = 0.028, analysis of variance (ANOVA)], indicating increased proteolysis. Nonoxidative leucine flux was higher after E than after saline administration (0.08 +/- 0.11 vs. -0.47 +/- 0.18 mumol/kg.min, P = 0.007, ANOVA), suggesting increased amino acid incorporation into proteins. E caused a transient decrease of plasma glucose concentration (by 0.5 +/- 0.1 mmol/L after 150 min; P < 0.004 vs. saline controls) due to a relative increase in disappearance compared to appearance of glucose (6,6 D2-glucose infusion technique). These alterations were associated with increases in plasma concentrations of ACTH, beta-lipoprotein (beta-LPH), GH, cortisol, epinephrine, free fatty acid, beta-hydroxybutyrate, and decreases of plasma insulin. Pretreatment with ibuprofen, a cyclooxygenase inhibitor, blunted the effects of E on whole body leucine flux (P < 0.05 vs. E) and on nonoxidative leucine flux (P < 0.05 vs. E) but enhanced the E-induced decrease of plasma glucose concentration (P < 0.004 vs. E), due to a relative increase in glucose disappearance compared to appearance (P = 0.02). The increases in counterregulatory hormones (ACTH, beta-LPH, GH, cortisol, epinephrine) were also attenuated by ibuprofen. Thus, acute endotoxinemia results in a redistribution of whole body proteins due to an increase in both protein breakdown and amino acid incorporation into proteins and in decreased plasma glucose concentrations. The ibuprofen data suggested that these effects of E on leucine kinetics, but not on glucose metabolism, were prostaglandin E2-mediated.


This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
S. N. van der Crabben, R. M. E. Blumer, M. E. Stegenga, M. T. Ackermans, E. Endert, M. W. T. Tanck, M. J. Serlie, T. van der Poll, and H. P. Sauerwein
Early Endotoxemia Increases Peripheral and Hepatic Insulin Sensitivity in Healthy Humans
J. Clin. Endocrinol. Metab., February 1, 2009; 94(2): 463 - 468.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. del Rey, E. Roggero, A. Randolf, C. Mahuad, S. McCann, V. Rettori, and H. O. Besedovsky
IL-1 resets glucose homeostasis at central levels
PNAS, October 24, 2006; 103(43): 16039 - 16044.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. O. Agwunobi, C. Reid, P. Maycock, R. A. Little, and G. L. Carlson
Insulin Resistance and Substrate Utilization in Human Endotoxemia
J. Clin. Endocrinol. Metab., October 1, 2000; 85(10): 3770 - 3778.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
N. Briard, V. Guillaume, C. Frachebois, M. Rico-Gomez, N. Sauze, C. Oliver, and A. Dutour
Endotoxin Injection Increases Growth Hormone and Somatostatin Secretion in Sheep
Endocrinology, June 1, 1998; 139(6): 2662 - 2669.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1993 by The Endocrine Society